Social media

New analyses show that well-implemented DHTs can: - Reduce trial timelines by 3–5 months - Decrease enrollment requirements by up to 16% - Lower protocol amendment risk - Deliver meaningful ROI in both Phase II and Phase...

New analyses show that well-implemented DHTs can: - Reduce trial timelines by 3–5 months - Decrease enrollment requirements by up to 16% - Lower protocol amendment risk - Deliver meaningful ROI in both Phase II and Phase...

Join us to explore the latest best practices in global flow cytometry QC and harmonisation. During this webinar hosted by Bioanalysis Zone ICON’s flow cytometry specialists will discuss: - Industry best practices for h...

Join us to explore the latest best practices in global flow cytometry QC and harmonisation. During this webinar hosted by Bioanalysis Zone ICON’s flow cytometry specialists will discuss: - Industry best practices for h...

Come along to Rüdiger Kaspera's Learning Lab at ASCPT, where he’ll dive into science and risk based strategies for designing oligonucleotide First‑in‑Human studies - covering toxicity, study design, PK/PD, population se...

Patient led organisations are shaping scientific and regulatory strategy in ultra rare diseases. Join our live panel as we bring together leaders whose work has contributed to gene therapies, accelerated approvals and ...

How do patient-led organisations help bring therapies to families faster? Our live webinar gathers relentless leaders to explore real world examples of patient-led innovation reshaping drug development and regulatory str...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

Flow cytometry is rapidly evolving - driven by high parameter and spectral technologies, smarter data analytics and global standardisation efforts. This Spotlight hosted by Bioanalysis Zone brings together leading expe...

Understanding how clinical trials are delivered starts with clarity on the roles that shape them. Our latest blog explains how sponsors set the research agenda and retain oversight, how CROs manage operational delivery...

Understanding how clinical trials are delivered starts with clarity on the roles that shape them. Our latest blog explains how sponsors set the research agenda and retain oversight, how CROs manage operational delivery...

AI enabled SaMD is evolving quickly. But are we addressing model bias fast enough? Our latest blog explores how bias creeps into datasets and what developers must do to avoid perpetuating disparities in healthcare. - Im...